These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 14561800)

  • 21. [Medullary thyroid gland carcinoma. Sporadic/familial. Screening when and why?].
    Frilling A; Liedke MO
    Internist (Berl); 1998 Jun; 39(6):588-91. PubMed ID: 9677514
    [No Abstract]   [Full Text] [Related]  

  • 22. [Prophylactic total thyroidectomy in children and adolescents with genetic mutations in the RET-protooncogene].
    Spinelli C; Puccini M; Bertocchini A; Lima M; Pacini F; Miccoli P
    Pediatr Med Chir; 2002; 24(1):53-7. PubMed ID: 11938683
    [TBL] [Abstract][Full Text] [Related]  

  • 23. RET proto-oncogene mutations affecting codon 790/791: A mild form of multiple endocrine neoplasia type 2A syndrome?
    Gimm O; Niederle BE; Weber T; Bockhorn M; Ukkat J; Brauckhoff M; Thanh PN; Frilling A; Klar E; Niederle B; Dralle H
    Surgery; 2002 Dec; 132(6):952-9; discussion 959. PubMed ID: 12490841
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Review of multiple endocrine neoplasia type 2A in children: therapeutic results of early thyroidectomy and prognostic value of codon analysis.
    Szinnai G; Meier C; Komminoth P; Zumsteg UW
    Pediatrics; 2003 Feb; 111(2):E132-9. PubMed ID: 12563086
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prophylactic thyroidectomy in MEN 2A syndrome.
    Mattavelli F; Seregni E; Collini P; Pasini B; Aiello A; Barbaccia C; Bimbi G; Riccio S; Santamaria S
    Tumori; 2003; 89(5):553-5. PubMed ID: 14870785
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic basis of endocrine disease: multiple endocrine neoplasia type 2.
    Mulligan LM; Ponder BA
    J Clin Endocrinol Metab; 1995 Jul; 80(7):1989-95. PubMed ID: 7608246
    [No Abstract]   [Full Text] [Related]  

  • 27. Adrenal and extra-adrenal pheochromocytomas in a family with germline RET V804L mutation.
    Nilsson O; Tisell LE; Jansson S; Ahlman H; Gimm O; Eng C
    JAMA; 1999 May; 281(17):1587-8. PubMed ID: 10235148
    [No Abstract]   [Full Text] [Related]  

  • 28. RET protooncogene analysis in the diagnosis of medullary thyroid carcinoma and multiple endocrine neoplasia type II.
    Matias-Guiu X
    Adv Anat Pathol; 1998 May; 5(3):196-201. PubMed ID: 9868525
    [No Abstract]   [Full Text] [Related]  

  • 29. Medullary thyroid carcinoma. Genetic screening and prophylactic thyroidectomies.
    Bergant D; Hocevar M
    Acta Chir Iugosl; 2003; 50(3):121-4. PubMed ID: 15179767
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Invited commentary: medullary thyroid cancer: the importance of RET testing.
    Evans DB; Shapiro SE; Cote GJ
    Surgery; 2007 Jan; 141(1):96-9. PubMed ID: 17188173
    [No Abstract]   [Full Text] [Related]  

  • 31. Predictive DNA testing for multiple endocrine neoplasia 2: a therapeutic challenge of prophylactic thyroidectomy in very young children.
    van Heurn LW; Schaap C; Sie G; Haagen AA; Gerver WJ; Freling G; van Amstel HK; Heineman E
    J Pediatr Surg; 1999 Apr; 34(4):568-71. PubMed ID: 10235324
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Update on the MEN 2A c804 RET mutation: is prophylactic thyroidectomy indicated?
    Frohnauer MK; Decker RA
    Surgery; 2000 Dec; 128(6):1052-7;discussion 1057-8. PubMed ID: 11114642
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prophylactic thyroidectomy in MEN 2A syndrome: experience in a single center.
    Rodríguez GJ; Balsalobre MD; Pomares F; Torregrosa NM; Ríos A; Carbonell P; Glower G; Sola J; Tébar J; Parrilla P
    J Am Coll Surg; 2002 Aug; 195(2):159-66. PubMed ID: 12168961
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Medullary carcinoma of the thyroid].
    Obara T
    Nihon Rinsho; 2006 May; Suppl 1():478-81. PubMed ID: 16776194
    [No Abstract]   [Full Text] [Related]  

  • 35. [Familial thyroid medullary carcinoma].
    Bartolomé Albistegui MJ; Rodrigo Palacios J; Schüffelmann Gutiérrez S; Merino Arribas JM; Ardela Díaz E; Camino Fernández AL
    An Esp Pediatr; 2002 Aug; 57(2):177-9. PubMed ID: 12139879
    [No Abstract]   [Full Text] [Related]  

  • 36. Very early manifestation of hereditary medullary thyroid cancer in carriers of intracellular-domain RET mutations.
    Machens A; Dralle H
    J Pediatr Surg; 2007 Jun; 42(6):1153; author reply 1154. PubMed ID: 17560241
    [No Abstract]   [Full Text] [Related]  

  • 37. Multiple endocrine neoplasia type 2 and the RET receptor--a disease spectrum comes of age.
    Soule S; Berman P
    S Afr Med J; 1997 Mar; 87(3 Suppl):357-8. PubMed ID: 9137354
    [No Abstract]   [Full Text] [Related]  

  • 38. [Prophylactic thyroid surgery].
    Frilling A; Weber F
    Chirurg; 2006 Jan; 77(1):6-14. PubMed ID: 16328197
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Polyadenomatoses: type 2 multiple endocrine neoplasms].
    Conte-Devolx B; Niccoli-Sire P;
    Presse Med; 2002 Aug; 31(26):1224-30. PubMed ID: 12212516
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Usefulness of RET proto-oncogene in the diagnosis of hereditary-type medullary carcinoma of the thyroid. Correlation with surgical findings].
    Carreño M; Girbés J; Malluguiza R; Serrano S; Matias-Guiu X; Tudela J; Alfayate R; Lagarda H
    Acta Otorrinolaringol Esp; 2001; 52(1):57-63. PubMed ID: 11269881
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.